The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
Abstract
Background and Purpose We sought to identify variables associated with intracerebral hemorrhage in patients with acute ischemic stroke who receive tissue plasminogen activator (t-PA). Methods We performed subgroup analyses of data from a randomized, double-blind, placebo-controlled trial of intravenous t-PA administered to stroke patients within 3 hours of onset. Using multivariable regression modeling procedures, we assessed the relationship of baseline and after-treatment variables with symptomatic and asymptomatic intracerebral hemorrhage during the first 36 hours after treatment. Results Overall, t-PA–treated patients had an increase in the absolute risk of symptomatic intracerebral hemorrhage of 6% and a decrease in the absolute risk of 3-month mortality of 4% compared with placebo-treated patients. The only variables independently associated with an increased risk of symptomatic intracerebral hemorrhage in the final multivariable logistic regression model for the 312 t-PA–treated patients were the severity of neurological deficit as measured by the National Institutes of Health Stroke Scale score (five categories; odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2 to 2.9) and brain edema (defined as acute hypodensity) or mass effect by CT before treatment (OR, 7.8; 95% CI, 2.2 to 27.1). This final model correctly predicted those t-PA–treated patients who would or would not have a symptomatic hemorrhage with only 57% efficiency. In the subgroup of patients with a severe neurological deficit, t-PA–treated patients were more likely than placebo-treated patients to have a favorable 3-month outcome (adjusted OR based on multiple outcomes, 4.3; 95% CI, 1.6 to 11.9). These results were similar for the subgroup with edema or mass effect by CT (adjusted OR, 3.4; 95% CI, 0.6 to 20.7). The likelihood of severe disability or death was similar for t-PA–and placebo-treated patients with these two baseline characteristics. Conclusions Despite a higher rate of intracerebral hemorrhage, patients with severe strokes or edema or mass effect on the baseline CT are reasonable candidates for t-PA, if it is administered within 3 hours of onset.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Self-citationBeneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
(1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250701 · Cited by 8,368
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Best Subsets Logistic Regression
Hosmer, D. W., Jovanovic, B., & Lemeshow, S. (1989) · Biometrics · doi:10.2307/2531779 · Cited by 1,176
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Mahoney, F. I., & Barthel, D. W. (2013) · PsycTESTS Dataset · doi:10.1037/t02366-000 · Cited by 887
Multicentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Regression, Prediction and Shrinkage
Copas, J. B. (1983) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1983.tb01258.x · Cited by 612
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350301 · Cited by 570
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Barber, P. A., Demchuk, A. M., Zhang, J., & Buchan, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02237-6 · Cited by 2,668
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
von Kummer, R., Broderick, J. P., Campbell, B. C. V., Demchuk, A., Goyal, M., Hill, M. D., Treurniet, K. M., Majoie, C. B. L. M., Marquering, H. A., Mazya, M. V., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010049 · Cited by 1,409
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Triggers, targets and treatments for thrombosis
Mackman, N. (2008) · Nature · doi:10.1038/nature06797 · Cited by 1,188
Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler, J. R., Tilley, B. C., Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1649 · Cited by 862
Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications
Simard, J. M., Kent, T. A., Chen, M., Tarasov, K. V., & Gerzanich, V. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70055-8 · Cited by 794
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N. (2008) · Chest · doi:10.1378/chest.08-0674 · Cited by 740
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: The Cleveland Area Experience
Katzan, I. L., Furlan, A. J., Lloyd, L. E., Frank, J. I., Harper, D. L., Hinchey, J. A., Hammel, J. P., Qu, A., & Sila, C. A. (2000) · JAMA · doi:10.1001/jama.283.9.1151 · Cited by 648
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans
Jickling, G. C., Liu, D., Stamova, B., Ander, B. P., Zhan, X., Lu, A., & Sharp, F. R. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.203 · Cited by 547
Yaghi, S., Willey, J. Z., Cucchiara, B., Goldstein, J. N., Gonzales, N. R., Khatri, P., Kim, L. J., Mayer, S. A., Sheth, K. N., & Schwamm, L. H. (2017) · Stroke · doi:10.1161/str.0000000000000152 · Cited by 545
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
Bruno, A., Levine, S. R., Frankel, M. R., Brott, T. G., Lin, Y., Tilley, B. C., Lyden, P. D., Broderick, J. P., Kwiatkowski, T. G., Fineberg, S. E., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.669 · Cited by 516
Self-citationSu, E. J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., Gao, Y., Pietras, K., Mann, K., Yepes, M., et al. (2008) · Nature Medicine · doi:10.1038/nm1787 · Cited by 468
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Lansberg, M. G., O'Donnell, M. J., Khatri, P., Lang, E. S., Nguyen-Huynh, M. N., Schwartz, N. E., Sonnenberg, F. A., Schulman, S., Vandvik, P. O., Spencer, F. A., et al. (2012) · Chest · doi:10.1378/chest.11-2302 · Cited by 455
Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment
Benowitz, N. L. (2003) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(03)00087-2 · Cited by 424
Khatri, P., Kleindorfer, D. O., Devlin, T., Sawyer, R. N., Starr, M., Mejilla, J., Broderick, J., Chatterjee, A., Jauch, E. C., Levine, S. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.8496 · Cited by 409
Treatment of Acute Ischemic Stroke
Brott, T., & Bogousslavsky, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431007 · Cited by 398
Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies
Pan, J., Konstas, A.-A., Bateman, B., Ortolano, G. A., & Pile-Spellman, J. (2007) · Neuroradiology · doi:10.1007/s00234-006-0183-z · Cited by 390
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management
Kruyt, N. D., Biessels, G. J., DeVries, J. H., & Roos, Y. B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.231 · Cited by 386
Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
Lakhan, S. E., Kirchgessner, A., Tepper, D., & Leonard, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00032 · Cited by 384
Bernardo-Castro, S., Sousa, J. A., Brás, A., Cecília, C., Rodrigues, B., Almendra, L., Machado, C., Santo, G., Silva, F., Ferreira, L., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.594672 · Cited by 381
Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications
Koennecke, H.-C. (2006) · Neurology · doi:10.1212/01.wnl.0000194266.55694.1e · Cited by 373
Bluhmki, E., Chamorro, Á., Dávalos, A., Machnig, T., Sauce, C., Wahlgren, N., Wardlaw, J., & Hacke, W. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70264-9 · Cited by 346
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial
Kase, C. S., Furlan, A. J., Wechsler, L. R., Higashida, R. T., Rowley, H. A., Hart, R. G., Molinari, G. F., Frederick, L. S., Roberts, H. C., Gebel, J. M., et al. (2001) · Neurology · doi:10.1212/wnl.57.9.1603 · Cited by 332
Association Between Obesity and Mortality After Acute First-Ever Stroke: The Obesity–Stroke Paradox
Vemmos, K., Ntaios, G., Spengos, K., Savvari, P., Vemmou, A., Pappa, T., Manios, E., Georgiopoulos, G., & Alevizaki, M. (2011) · Stroke · doi:10.1161/strokeaha.110.593434 · Cited by 324
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100
Saposnik, G., Guzik, A. K., Reeves, M., Ovbiagele, B., & Johnston, S. C. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b1ace · Cited by 316
Comparison of diffusion-weighted MRI and CT in acute stroke
Lansberg, M. G., Albers, G. W., Beaulieu, C., & Marks, M. P. (2000) · Neurology · doi:10.1212/wnl.54.8.1557 · Cited by 299
Zhu, Z., Fu, Y., Tian, D., Sun, N., Han, W., Chang, G., Dong, Y., Xu, X., Liu, Q., Huang, D., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016371 · Cited by 291
Lev, M. H., Farkas, J., Rodriguez, V. R., Schwamm, L. H., Hunter, G. J., Putman, C. M., Rordorf, G. A., Buonanno, F. S., Budzik, R., Koroshetz, W. J., et al. (2001) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200107000-00003 · Cited by 284
Lev, M. H., Farkas, J., Gemmete, J. J., Hossain, S. T., Hunter, G. J., Koroshetz, W. J., & Gonzalez, R. G. (1999) · Radiology · doi:10.1148/radiology.213.1.r99oc10150 · Cited by 271
Factors influencing haemorrhagic transformation in ischaemic stroke
Álvarez-Sabín, J., Maisterra, O., Santamarina, E., & Kase, C. S. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70055-3 · Cited by 270
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub2 · Cited by 267
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
DEL ZOPPO, G. J., VON KUMMER, R., & HAMANN, G. F. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.1 · Cited by 261
Evidence for Apoptosis After Intracerebral Hemorrhage in Rat Striatum
Matsushita, K., Meng, W., Wang, X., Asahi, M., Asahi, K., Moskowitz, M. A., & Lo, E. H. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00022 · Cited by 254
The HAT Score: A simple grading scale for predicting hemorrhage after thrombolysis
Lou, M., Safdar, A., Mehdiratta, M., Kumar, S., Schlaug, G., Caplan, L., Searls, D., & Selim, M. (2008) · Neurology · doi:10.1212/01.wnl.0000330297.58334.dd · Cited by 252
Machine learning for outcome prediction of acute ischemic stroke post intra-arterial therapy
Asadi, H., Dowling, R., Yan, B., & Mitchell, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088225 · Cited by 218
11 C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage
Ly, J. V., Donnan, G. A., Villemagne, V. L., Zavala, J. A., Ma, H., O'Keefe, G., Gong, S. J., Gunawan, R. M., Saunder, T., Ackerman, U., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cef7e3 · Cited by 157
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage
Morimoto, N., Shimazawa, M., Yamashima, T., Nagai, H., & Hara, H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.062 · Cited by 137
Cytoprotective protein C pathways and implications for stroke and neurological disorders
Zlokovic, B. V., & Griffin, J. H. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.005 · Cited by 128
Jia, L., Chopp, M., Zhang, L., Lu, M., & Zhang, Z. (2010) · Stroke · doi:10.1161/strokeaha.110.586198 · Cited by 62
Goncalves, A., & Antonetti, D. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00386-0 · Cited by 22
Mechanical thrombectomy for the treatment of acute ischemic stroke
Fields, J. D., Lindsay, K., Liu, K. C., Nesbit, G. M., & Lutsep, H. L. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.8 · Cited by 16
Metadata
- Authors
- The NINDS t-PA Stroke Study Group
- Venue
- Stroke
- Published
- 1997-11
- Volume
- 28
- Issue
- 11
- Pages
- 2109-2118
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W4250104750
- Cited by
- 880
- References
- 14
- FWCI
- 22.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.